These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 15280539)

  • 1. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
    Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
    Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
    J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
    Arriagada G; Muntean LN; Goff SP
    PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
    Perron MJ; Stremlau M; Sodroski J
    J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
    Berthoux L; Sebastian S; Sayah DM; Luban J
    J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
    Yap MW; Nisole S; Lynch C; Stoye JP
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
    Rold CJ; Aiken C
    PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
    Sokolskaja E; Berthoux L; Luban J
    J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
    Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
    J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
    Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
    PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
    Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
    Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
    Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
    J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
    Keckesova Z; Ylinen LM; Towers GJ
    J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
    Ylinen LM; Keckesova Z; Wilson SJ; Ranasinghe S; Towers GJ
    J Virol; 2005 Sep; 79(18):11580-7. PubMed ID: 16140735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.